News on Evangeline Lilly

87 days ago

There has been 18 news on Evangeline Lilly in the past from 9 sources across 4 sections.

Access to all news on this scope:

See the trend on this scope:

Evolution through time

Sentiment analysis

Current sentiment polarity: neutral with a score of 0

Sentiment polarity through time

Latest news

Click on the source to read the entire article:

RFK Jr. on Ozempic, Eli Lilly's next test, and Elon Musk gets on the bandwagon: Pharma news roundup

Quartz
87d ago

Lilly invests $3 billion to expand Wisconsin plant as obesity drug demand soars

CNBC News
95d ago

Scoop: Trump, RFK Jr. dine with Pfizer and Lilly execs

Axios
95d ago

Medicaid dominates coverage of Novo, Lilly weight-loss drugs

Fast Company
112d ago

U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug

CNBC News
149d ago

Lilly Fires Warning Shot at Copycat Drug Makers After Shortage

Bloomberg
151d ago

Lilly slashes prices on lowest doses of weight loss drug Zepbound

NBC News
194d ago

Lilly's weight-loss drug cuts diabetes risk by 94% in three-year trial, company says

NBC News
200d ago

Lilly Gains in Obesity Race With Novo as Supplies Expand

Bloomberg
214d ago

FDA approves Lilly's new Alzheimer's drug after delay

The Hill
251d ago

FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval

CNBC News
273d ago

China Urges Lilly to Boost Investing Amid US Cutoff Threat

Bloomberg
353d ago

In an unusual move, FDA postpones approval decision for Lilly's Alzheimer's drug

NBC News
367d ago

Berkshire and Lilly race to shake tech's grip on trillion-dollar club

Phys
375d ago

Patients regain weight after stopping Eli Lilly's Zepbound, study says

CNBC News
455d ago

Lilly to build $2.5 billion Germany plant as obesity drug demand soars

Reuters
479d ago

Lilly trades at a premium to Ozempic maker Novo as obesity drugs boom. Here's why, analyst says

CNBC News
486d ago

FDA approves Eli Lilly's tirzepatide for weight loss, paving way for wider use of blockbuster drug

CNBC News
487d ago

Sections

The coverage spans across 4 sections:

Sources

There has been 9 news sources reporting on this, including: CNBC News (33%), NBC News (17%), Bloomberg (17%), The Hill (6%), and Reuters (6%).

Going further

Stay up to date:

Details

This content is available under the CC BY 4.0 license.